Evaluation of the seroprevalence of measles, rubella, mumps, and varicella and the requirement for additional vaccination based on the JSIPC guidelines among emergency medical technicians at eight fire stations in Narita, Japan: a project review.
Japan
Seroprevalence
emergency medical technician
paramedic
vaccination
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
31 12 2022
31 12 2022
Historique:
pubmed:
11
11
2021
medline:
19
4
2022
entrez:
10
11
2021
Statut:
ppublish
Résumé
Limited data are available regarding the seroprevalence of measles, mumps, rubella, and varicella (MMRV) among emergency medical technicians (EMTs) in Japan. The present study aimed to review a project to evaluate adequate immunity against MMRV for the requirement of additional vaccination among EMTs in accordance with the Japanese Society for Infection Prevention and Control guidelines. A retrospective observational study was conducted as part of a vaccination program for EMTs. Each participant was evaluated for medical history, vaccination history, and serology using the criteria established by the Japanese Society of Infection Prevention and Control. In total, 85 EMTs (median age, 31 years; male, 92.9%) were included. Among the included EMTs, 32 (37.6%), 54 (63.5%), 46 (54.1%), and 84 (98.9%) were seropositive for measles, rubella, mumps, and varicella, respectively, whereas 1 (1.2%), 6 (7.1%), 5 (5.9%), and 0 (0%) were seronegative. Furthermore, 48 (56.5%), 27 (31.8%), 45 (52.9%), and 8 (9.4%) EMTs received an additional dose of vaccines for measles, rubella, mumps, and varicella, respectively. The present study suggests that EMTs are not fully immune to MMRV, which highlights the need for confirming the immune status and additional vaccination requirement to prevent occupational infections.
Identifiants
pubmed: 34756159
doi: 10.1080/21645515.2021.1989922
pmc: PMC9891669
doi:
Substances chimiques
Antibodies, Viral
0
Chickenpox Vaccine
0
Measles-Mumps-Rubella Vaccine
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1989922Références
Jpn J Infect Dis. 2003 Jun;56(3):81-7
pubmed: 12944671
Vaccine. 2016 Apr 7;34(16):1965-70
pubmed: 26944711
Infect Prev Pract. 2019 Aug 17;1(2):100018
pubmed: 34368679
Ther Adv Vaccines Immunother. 2020 Oct 28;8:2515135520967203
pubmed: 33681700
Infect Control Hosp Epidemiol. 2004 Jul;25(7):591-4
pubmed: 15301032
PLoS One. 2020 Mar 24;15(3):e0230329
pubmed: 32208432
Lancet. 2004 Jul 24-30;364(9431):328-9
pubmed: 15276387
J Infect Chemother. 2013 Oct;19(5):787-98
pubmed: 23835871
J Epidemiol. 2021 Aug 5;31(8):464-470
pubmed: 32684528
J Infect Chemother. 2019 Jan;25(1):78-81
pubmed: 30064948
Ann Intern Med. 2011 Mar 15;154(6):391-400
pubmed: 21403075